Related references
Note: Only part of the references are listed.Structural and Functional Insights of RANKL-RANK Interaction and Signaling
Changzhen Liu et al.
JOURNAL OF IMMUNOLOGY (2010)
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
Daniel Schramek et al.
NATURE (2010)
Structure-based development of a receptor activator of nuclear factor-κB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis
Hai Minh Ta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The affinity of human RANK binding to its ligand RANKL
Shiqian Zhang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
CHARMM: The Biomolecular Simulation Program
B. R. Brooks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Mutations within the TNF-Like Core Domain of RANKL Impair Osteoclast Differentiation and Activation
Taksum Cheng et al.
MOLECULAR ENDOCRINOLOGY (2009)
Central control of fever and female body temperature by RANKL/RANK
Reiko Hanada et al.
NATURE (2009)
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Matthew R. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Metabolic activation of a novel 3-substituted indole-containing TNF-α inhibitor:: Dehydrogenation and inactivation of CYP3A4
Hao Sun et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Inhibition of RANKL-mediated osteoclast differentiation by selective TRAF6 decoy peptides
Ann T. Poblenz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL
Cristina Sobacchi et al.
NATURE GENETICS (2007)
RANK signals from CD4+3- inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla
Simona W. Rossi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Hiroshi Takayanagi
NATURE REVIEWS IMMUNOLOGY (2007)
Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand
Atsuhiko Hikita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration
Brian T. Feeley et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss
Kazuhiro Aoki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Regulation of cancer cell migration and bone metastasis by RANKL
DH Jones et al.
NATURE (2006)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
R/qtl: QTL mapping in experimental crosses
KW Broman et al.
BIOINFORMATICS (2003)
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases
JJ Body et al.
CANCER (2003)
Vitamin D and bone
T Suda et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Reaching a genetic and molecular understanding of skeletal development
G Karsenty et al.
DEVELOPMENTAL CELL (2002)
Crystal structure of the extracellular domain of mouse RANK ligand at 2.2-Å resolution
S Ito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity
J Lam et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Genome-wide ENU mutagenesis to reveal immune regulators
KA Nelms et al.
IMMUNITY (2001)
Heterotrimers formed by tumor necrosis factors of different species or muteins
P Ameloot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-κB ligand
JK Xu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
JE Fata et al.
CELL (2000)
Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene
N Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo
DL Lacey et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Genome-wide, large-scale production of mutant mice by ENU mutagenesis
MH de Angelis et al.
NATURE GENETICS (2000)
Effects of ENU dosage on mouse strains
MJ Justice et al.
MAMMALIAN GENOME (2000)
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
J Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
